Cases & Deals

Implanet completes €7 million rights issue

Clients Implanet SA

Jones Day advised Implanet SA, a medical technology company specializing in vertebral and knee-surgery implants, as well as SwissLife Banque Privée, in connection with the €7 million (US$7.5 million) rights issue of new and existing shares.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.